Hinova Pharmaceuticals Inc

688302

Company Profile

  • Business description

    Hinova Pharmaceuticals Inc is an international drug company based on technology platforms such as deuterium and PROTAC, aiming to develop Best-in-class and First-in-class drugs with major clinical needs. The company focuses on the research and development of drugs in therapeutic areas such as oncology and metabolic diseases, focusing on providing safe, effective and affordable drugs for patients, and is committed to the development and production of drugs with global rights and interests.

  • Contact

    No. 5 Keyuan South Road
    No. 2 and 3, 4th Floor, Building 1, Rongyao Building
    High-tech Zone, Sichuan Province
    Chengdu610041
    CHN

    T: +86 2885058465

    http://www.hinovapharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    174

Stocks News & Analysis

stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.
stocks

Coca-Cola earnings: Innovation and brand strength underpin growth

We plan to raise our fair value estimate of Coca-Cola stock.
stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,314.8017.10-0.18%
CAC 408,258.8652.790.64%
DAX 4024,330.0371.230.29%
Dow JONES (US)46,924.74218.160.47%
FTSE 1009,426.9923.420.25%
HKSE25,697.57329.98-1.27%
NASDAQ22,953.6736.88-0.16%
Nikkei 22549,372.6856.620.11%
NZX 50 Index13,306.4471.41-0.53%
S&P 5006,735.350.220.00%
S&P/ASX 2009,026.3014.00-0.15%
SSE Composite Index3,899.0517.28-0.44%

Market Movers